Abstract
OXA-72 has been reported in few countries around the world. We report the first case in Colombia in an Acinetobacter pittii clinical isolate. The arrival of a new OXA, into a country with high endemic resistance, poses a significant threat, especially because the potential for widespread dissemination is considerable. Copyright © 2012, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Montealegre, M. C., Maya, J. J., Correa, A., Espinal, P., Mojica, M. F., Ruiz, S. J., … Villegas, M. V. (2012). First identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia. Antimicrobial Agents and Chemotherapy, 56(7), 3996–3998. https://doi.org/10.1128/AAC.05628-11
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
